1)Burt RW, Witt RM, Cikrit DF, Reddy RV:Carotid artery disease:evaluation with acetazolamide-enhanced Tc-99m HMPAO SPECT. Radiology 182:461-466, 1992
2)Choksi V, Hughes M, Selwa L, Hoeffner E:Transient neurologic deficit after acetazolamide challengi for computed tomography perfusion imaging. J Comput Assist Tomogr 29:278-280, 2005
3)Hauge A, Nicolaysen G, Yhoresen M:Acute effects of acetazolamide on cerebral blood flow in man. Acta Physiol Scand 117:233-239, 1983
4)JET Study Group:Japanese EC-IC Bypass Trial (JET Study):Study designと中間解析結果.脳卒中の外科30:97-100, 2002
5)Komiyama M, Nishikawa M, Yasui T, Sakamoto H:Reversible pontine ischemia caused by acetazolamide challenge. AJNR Am J Neuroradiol 18:1782-1784, 1996
6)黒田 敏:脳血行再建と脳循環・代謝.pp36-73(宝金清博 編:脳血行再建の理論と実際.1章,3節,中外医学社,東京,2006)
7)Kuroda S, Kamiyama H, Abe H, Houkin K, Isobe M, Mitsumori K:Acetazolamide test in detecting reduced cerebral perfusion reverse and predicting long-term prognosis in patinets woth internal carotid artery occlusion. Neurosurgery 32:912-919, 1993
8)Posner JB, Plum F:The toxic effects of carbon dioxide and acetazolamide in hepatic encephalopathy. J Clin Invest 39:1246-1258, 1960
9)Sullivian HG, Kingsbury TB, Morgan ME, Jeffcoat RD, Allison JD, Goode JJ, McDonnell DE:The rCBF response to Diamox in normal subjects and cerebrovascular disease patients. J Neurosurg 67:525-534, 1987